Andrew Levin
Principal investigator, leads Eliem Therapeutics, Inc. and Imbria Pharmaceuticals and IMMUNETICS, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.6MFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $4.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Dec 1, 2015 | NIH | SBIR Phase II Rapid, Near-Tranfusion Test for Bacteria in Platelets Units | $972K | IMMUNETICS, INC. |
| Apr 1, 2015 | NIH | SBIR Phase II Immunoassay for diagnosis of Babesia infection | $3.6M | IMMUNETICS, INC. |
Peer ranks
Federal funding#311
Awards as PI#1,252
Patents#273
Companies
- Eliem Therapeutics, Inc.Leads (SEC Form D) · Biotech
- Imbria PharmaceuticalsLeads (SEC Form D) · Biotech
- IMMUNETICS, INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.